デュシェンヌ型筋ジストロフィー治療薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Duchenne Muscular Dystrophy Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST05270 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、デュシェンヌ型筋ジストロフィー治療薬の世界市場について調査・分析し、デュシェンヌ型筋ジストロフィー治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（疼痛管理薬、コルチコステロイド、プレドニゾロン、プレドニゾン、デフラザコート）、用途別（病院、診療所、在宅ケア設定）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のデュシェンヌ型筋ジストロフィー治療薬市場動向 ・主要企業別マーケットシェア ・デュシェンヌ型筋ジストロフィー治療薬の種類別市場規模2014-2019 （疼痛管理薬、コルチコステロイド、プレドニゾロン、プレドニゾン、デフラザコート） ・デュシェンヌ型筋ジストロフィー治療薬の用途別市場規模2014-2019 （病院、診療所、在宅ケア設定） ・デュシェンヌ型筋ジストロフィー治療薬の北米市場：主要企業・種類別/用途別市場規模 ・デュシェンヌ型筋ジストロフィー治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・デュシェンヌ型筋ジストロフィー治療薬の中国市場：主要企業・種類別/用途別市場規模 ・デュシェンヌ型筋ジストロフィー治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・デュシェンヌ型筋ジストロフィー治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・デュシェンヌ型筋ジストロフィー治療薬のインド市場：主要企業・種類別/用途別市場規模 ・デュシェンヌ型筋ジストロフィー治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol-Myers Squibb、FibroGen (U.S.)、Italfarmaco (Italy)、Marathon、NS Pharma (U.S.)、PTC Therapeutics (U.S.)、Pfizer、ReveraGen BioPharma (U.S.)、Santhera Pharmaceuticals (Switzerland)、Sarepta Therapeutics (U.S.)） ・デュシェンヌ型筋ジストロフィー治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Duchenne muscular dystrophy (DMD) therapeutics helps treat genetic disorder caused due to absence of dystrophin, a protein in the body. The symptoms of the disease include weakness in the muscles of the hips, pelvic area, thighs, and shoulders, and later in the muscles of arms, legs, and trunk.Factors such as, increase in incidences of Duchenne muscular dystrophy and introduction of specific guidance for development for Duchenne muscular dystrophy drugs by FDA drive the market growth. However, fast track approval of these drugs by FDA and untapped growth opportunities in the emerging economies of Asia-Pacific and LAMEA are expected to fuel the market growth during the forecast period.
In 2018, the global Duchenne Muscular Dystrophy Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Duchenne Muscular Dystrophy Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Duchenne Muscular Dystrophy Therapeutics development in United States, Europe and China.

The key players covered in this study
Bristol-Myers Squibb
FibroGen (U.S.)
Italfarmaco (Italy)
Marathon
NS Pharma (U.S.)
PTC Therapeutics (U.S.)
Pfizer
ReveraGen BioPharma (U.S.)
Santhera Pharmaceuticals (Switzerland)
Sarepta Therapeutics (U.S.)

Market segment by Type, the product can be split into
Pain Management Drugs
Corticosteroids
Prednisolone
Prednisone
Deflazacort

Market segment by Application, split into
Hospitals
Clinics
Home Care Settings

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Duchenne Muscular Dystrophy Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Duchenne Muscular Dystrophy Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Duchenne Muscular Dystrophy Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Duchenne Muscular Dystrophy Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Pain Management Drugs
1.4.3 Corticosteroids
1.4.4 Prednisolone
1.4.5 Prednisone
1.4.6 Deflazacort
1.5 Market by Application
1.5.1 Global Duchenne Muscular Dystrophy Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home Care Settings
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Duchenne Muscular Dystrophy Therapeutics Market Size
2.2 Duchenne Muscular Dystrophy Therapeutics Growth Trends by Regions
2.2.1 Duchenne Muscular Dystrophy Therapeutics Market Size by Regions (2014-2025)
2.2.2 Duchenne Muscular Dystrophy Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Duchenne Muscular Dystrophy Therapeutics Market Size by Manufacturers
3.1.1 Global Duchenne Muscular Dystrophy Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Duchenne Muscular Dystrophy Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Duchenne Muscular Dystrophy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Duchenne Muscular Dystrophy Therapeutics Key Players Head office and Area Served
3.3 Key Players Duchenne Muscular Dystrophy Therapeutics Product/Solution/Service
3.4 Date of Enter into Duchenne Muscular Dystrophy Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2014-2019)
4.2 Global Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Duchenne Muscular Dystrophy Therapeutics Market Size (2014-2019)
5.2 Duchenne Muscular Dystrophy Therapeutics Key Players in United States
5.3 United States Duchenne Muscular Dystrophy Therapeutics Market Size by Type
5.4 United States Duchenne Muscular Dystrophy Therapeutics Market Size by Application

6 Europe
6.1 Europe Duchenne Muscular Dystrophy Therapeutics Market Size (2014-2019)
6.2 Duchenne Muscular Dystrophy Therapeutics Key Players in Europe
6.3 Europe Duchenne Muscular Dystrophy Therapeutics Market Size by Type
6.4 Europe Duchenne Muscular Dystrophy Therapeutics Market Size by Application

7 China
7.1 China Duchenne Muscular Dystrophy Therapeutics Market Size (2014-2019)
7.2 Duchenne Muscular Dystrophy Therapeutics Key Players in China
7.3 China Duchenne Muscular Dystrophy Therapeutics Market Size by Type
7.4 China Duchenne Muscular Dystrophy Therapeutics Market Size by Application

8 Japan
8.1 Japan Duchenne Muscular Dystrophy Therapeutics Market Size (2014-2019)
8.2 Duchenne Muscular Dystrophy Therapeutics Key Players in Japan
8.3 Japan Duchenne Muscular Dystrophy Therapeutics Market Size by Type
8.4 Japan Duchenne Muscular Dystrophy Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size (2014-2019)
9.2 Duchenne Muscular Dystrophy Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size by Type
9.4 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size by Application

10 India
10.1 India Duchenne Muscular Dystrophy Therapeutics Market Size (2014-2019)
10.2 Duchenne Muscular Dystrophy Therapeutics Key Players in India
10.3 India Duchenne Muscular Dystrophy Therapeutics Market Size by Type
10.4 India Duchenne Muscular Dystrophy Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Duchenne Muscular Dystrophy Therapeutics Market Size (2014-2019)
11.2 Duchenne Muscular Dystrophy Therapeutics Key Players in Central & South America
11.3 Central & South America Duchenne Muscular Dystrophy Therapeutics Market Size by Type
11.4 Central & South America Duchenne Muscular Dystrophy Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.1.4 Bristol-Myers Squibb Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 FibroGen (U.S.)
12.2.1 FibroGen (U.S.) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.2.4 FibroGen (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.2.5 FibroGen (U.S.) Recent Development
12.3 Italfarmaco (Italy)
12.3.1 Italfarmaco (Italy) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.3.4 Italfarmaco (Italy) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.3.5 Italfarmaco (Italy) Recent Development
12.4 Marathon
12.4.1 Marathon Company Details
12.4.2 Company Description and Business Overview
12.4.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.4.4 Marathon Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.4.5 Marathon Recent Development
12.5 NS Pharma (U.S.)
12.5.1 NS Pharma (U.S.) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.5.4 NS Pharma (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.5.5 NS Pharma (U.S.) Recent Development
12.6 PTC Therapeutics (U.S.)
12.6.1 PTC Therapeutics (U.S.) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.6.4 PTC Therapeutics (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.6.5 PTC Therapeutics (U.S.) Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.7.4 Pfizer Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 ReveraGen BioPharma (U.S.)
12.8.1 ReveraGen BioPharma (U.S.) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.8.4 ReveraGen BioPharma (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.8.5 ReveraGen BioPharma (U.S.) Recent Development
12.9 Santhera Pharmaceuticals (Switzerland)
12.9.1 Santhera Pharmaceuticals (Switzerland) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.9.4 Santhera Pharmaceuticals (Switzerland) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.9.5 Santhera Pharmaceuticals (Switzerland) Recent Development
12.10 Sarepta Therapeutics (U.S.)
12.10.1 Sarepta Therapeutics (U.S.) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Duchenne Muscular Dystrophy Therapeutics Introduction
12.10.4 Sarepta Therapeutics (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
12.10.5 Sarepta Therapeutics (U.S.) Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Duchenne Muscular Dystrophy Therapeutics Key Market Segments
Table Key Players Duchenne Muscular Dystrophy Therapeutics Covered
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Market Share by Type 2014-2025
Figure Pain Management Drugs Figures
Table Key Players of Pain Management Drugs
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure Prednisolone Figures
Table Key Players of Prednisolone
Figure Prednisone Figures
Table Key Players of Prednisone
Figure Deflazacort Figures
Table Key Players of Deflazacort
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Home Care Settings Case Studies
Figure Duchenne Muscular Dystrophy Therapeutics Report Years Considered
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Share by Regions 2014-2019
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Share by Regions 2014-2019
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Duchenne Muscular Dystrophy Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Share by Manufacturers in 2018
Table Global Duchenne Muscular Dystrophy Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Duchenne Muscular Dystrophy Therapeutics Product/Solution/Service
Table Date of Enter into Duchenne Muscular Dystrophy Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Type (2014-2019)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Application (2014-2019)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Duchenne Muscular Dystrophy Therapeutics Revenue Market Share by Application in 2018
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Duchenne Muscular Dystrophy Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Duchenne Muscular Dystrophy Therapeutics Market Share (2018-2019)
Table United States Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Duchenne Muscular Dystrophy Therapeutics Market Share by Type (2014-2019)
Table United States Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Duchenne Muscular Dystrophy Therapeutics Market Share by Application (2014-2019)
Figure Europe Duchenne Muscular Dystrophy Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Duchenne Muscular Dystrophy Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Duchenne Muscular Dystrophy Therapeutics Market Share (2018-2019)
Table Europe Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Duchenne Muscular Dystrophy Therapeutics Market Share by Type (2014-2019)
Table Europe Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Duchenne Muscular Dystrophy Therapeutics Market Share by Application (2014-2019)
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Duchenne Muscular Dystrophy Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Duchenne Muscular Dystrophy Therapeutics Market Share (2018-2019)
Table China Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Duchenne Muscular Dystrophy Therapeutics Market Share by Type (2014-2019)
Table China Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Duchenne Muscular Dystrophy Therapeutics Market Share by Application (2014-2019)
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Duchenne Muscular Dystrophy Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Duchenne Muscular Dystrophy Therapeutics Market Share (2018-2019)
Table Japan Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Duchenne Muscular Dystrophy Therapeutics Market Share by Type (2014-2019)
Table Japan Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Duchenne Muscular Dystrophy Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Duchenne Muscular Dystrophy Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Duchenne Muscular Dystrophy Therapeutics Market Share (2018-2019)
Table Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Share by Application (2014-2019)
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Duchenne Muscular Dystrophy Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Duchenne Muscular Dystrophy Therapeutics Market Share (2018-2019)
Table India Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Duchenne Muscular Dystrophy Therapeutics Market Share by Type (2014-2019)
Table India Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Duchenne Muscular Dystrophy Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Duchenne Muscular Dystrophy Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Duchenne Muscular Dystrophy Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Duchenne Muscular Dystrophy Therapeutics Market Share (2018-2019)
Table Central & South America Duchenne Muscular Dystrophy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Duchenne Muscular Dystrophy Therapeutics Market Share by Type (2014-2019)
Table Central & South America Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Duchenne Muscular Dystrophy Therapeutics Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table FibroGen (U.S.) Company Details
Table FibroGen (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)(Million US$)
Figure FibroGen (U.S.) Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table FibroGen (U.S.) Recent Development
Table Italfarmaco (Italy) Company Details
Table Italfarmaco (Italy) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)(Million US$)
Figure Italfarmaco (Italy) Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table Italfarmaco (Italy) Recent Development
Table Marathon Company Details
Table Marathon Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)(Million US$)
Figure Marathon Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table Marathon Recent Development
Table NS Pharma (U.S.) Company Details
Table NS Pharma (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)(Million US$)
Figure NS Pharma (U.S.) Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table NS Pharma (U.S.) Recent Development
Table PTC Therapeutics (U.S.) Company Details
Table PTC Therapeutics (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)(Million US$)
Figure PTC Therapeutics (U.S.) Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table PTC Therapeutics (U.S.) Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table ReveraGen BioPharma (U.S.) Company Details
Table ReveraGen BioPharma (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)(Million US$)
Figure ReveraGen BioPharma (U.S.) Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table ReveraGen BioPharma (U.S.) Recent Development
Table Santhera Pharmaceuticals (Switzerland) Company Details
Table Santhera Pharmaceuticals (Switzerland) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)(Million US$)
Figure Santhera Pharmaceuticals (Switzerland) Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table Santhera Pharmaceuticals (Switzerland) Recent Development
Table Sarepta Therapeutics (U.S.) Company Details
Table Sarepta Therapeutics (U.S.) Revenue in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)(Million US$)
Figure Sarepta Therapeutics (U.S.) Revenue Growth Rate in Duchenne Muscular Dystrophy Therapeutics Business (2014-2019)
Table Sarepta Therapeutics (U.S.) Recent Development
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size Share by Regions in 2025
Figure United States Duchenne Muscular Dystrophy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Duchenne Muscular Dystrophy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Duchenne Muscular Dystrophy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Duchenne Muscular Dystrophy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Duchenne Muscular Dystrophy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Duchenne Muscular Dystrophy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size by Product (2019-2025)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size by Product in 2025
Table Global Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size by Application (2019-2025)
Figure Global Duchenne Muscular Dystrophy Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---